Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=poznLatest Financial News for Pozen, Inc.en-usFri, 11 Dec 2009 15:45:56 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/pozn8-k.htmlyahoo_finance/3806793593Fri, 11 Dec 2009 15:45:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091207/179802.html?.v=1yahoo_finance/3774160024Mon, 7 Dec 2009 18:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091203/pozn8-k.htmlyahoo_finance/3735661270Thu, 3 Dec 2009 13:15:25 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091203/20091203005190.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. will hold an analyst and investor event on Tuesday, December 8th from 7:30 a.m. to 11:30 a.m. Eastern time at NASDAQ Marketsite in New York City. John R.yahoo_finance/1405785598Thu, 3 Dec 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091120/27505.html?.v=1Pozen is developing PA-325/40 for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers.yahoo_finance/1080493528Fri, 20 Nov 2009 17:17:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091120/20091120005118.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. announced today the start of enrollment for the phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325 mg of enteric coated aspirin and 40 mg of immediate release omeprazole, under investigation for use in the secondary prevention of heart attacks and strokes in patients at risk for associated gastric ulcers.yahoo_finance/37169906Fri, 20 Nov 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=poznyahoo_finance/2579651239Fri, 6 Nov 2009 14:04:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091102/pozn10-q.htmlyahoo_finance/700647673Mon, 2 Nov 2009 21:15:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091030/20091030005060.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. announced today that John R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief Executive Officer, will present at the Credit Suisse Healthcare Conference on Friday, November 13, 2009 at 8:30 a.m. , at the Arizona Biltmore hotel in Phoenix.yahoo_finance/325040918Fri, 30 Oct 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12c08536o/*http%3A//triangle.bizjournals.com/triangle/stories/2009/10/26/daily29.html?ana=yfcpcyahoo_finance/2425917042Wed, 28 Oct 2009 15:05:19 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/6/108126.htmlyahoo_finance/1542498665Wed, 28 Oct 2009 15:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091028/26537.html?.v=1yahoo_finance/184966121Wed, 28 Oct 2009 12:53:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091028/pozn8-k.htmlyahoo_finance/49440423Wed, 28 Oct 2009 11:56:39 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091028/20091028005177.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. , today announced results for the third quarter ended September 30, 2009.yahoo_finance/2175803241Wed, 28 Oct 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091028.html?t=poznyahoo_finance/215087397Wed, 28 Oct 2009 11:07:48 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091027/20091027005071.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses of over-the-counter enteric-coated aspirin in healthy adults treated for one month.yahoo_finance/3082340840Tue, 27 Oct 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091019/ph94480.html?.v=1AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology 2009 Annual Scientific Meeting in Philadelphia, PA.yahoo_finance/103283686Mon, 19 Oct 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091014/20091014005098.html?.v=1CHAPEL HILL, N.C.----POZEN Inc. , announced today that it will release third quarter 2009 results on October 28, 2009, before the market opens.yahoo_finance/2221933031Wed, 14 Oct 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090930/pozn8-k.htmlyahoo_finance/2843058032Wed, 30 Sep 2009 20:04:55 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090930/20090930006250.html?.v=1yahoo_finance/757198000Wed, 30 Sep 2009 20:00:00 Etc/GMT